Cardiac Endotheliitis and Multisystem Inflammatory Syndrome After COVID-19
Authors: Sharon E. Fox, Fernanda S. Lameira, Elizabeth B. Rinker, Richard S. Vander Heide
Journal: Annals of Internal Medicine (2020)

Letters29 July 2020Cardiac Endotheliitis and Multisystem Inflammatory Syndrome After COVID-19FREESharon E. Fox, MD, PhD, Fernanda S. Lameira, MD, Elizabeth B. Rinker, MD, and Richard S. Vander Heide, MD, PhDSharon E. Fox, MD, PhDLouisiana State University Health Sciences Center and Southeast Louisiana Veterans Health Care System, New Orleans, Louisiana (S.E.F.)Search for more papers by this author, Fernanda S. Lameira, MDLouisiana State University Health Sciences Center, New Orleans, Louisiana (F.S.L., E.B.R., R.S.V.)Search for more papers by this author, Elizabeth B. Rinker, MDLouisiana State University Health Sciences Center, New Orleans, Louisiana (F.S.L., E.B.R., R.S.V.)Search for more papers by this author, and Richard S. Vander Heide, MD, PhDLouisiana State University Health Sciences Center, New Orleans, Louisiana (F.S.L., E.B.R., R.S.V.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/L20-0882 SectionsAboutVisual AbstractPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Background: Endotheliitis and microangiopathy have been identified as key features of the pathophysiology of severe coronavirus disease 2019 (COVID-19) (1, 2). In addition, a multisystem inflammatory syndrome (MIS) similar to Kawasaki disease has been increasingly reported in association with COVID-19 in children and young adults (3–5). Although vascular damage seems to be a component of both of these presentations, the pathologic features of MIS remain elusive.Objective: To provide what we believe to be the first report on the pathologic findings of vasculitis of the small vessels of the heart, which likely represents MIS, leading to death in a young adult after presumed resolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.Case Report: The patient was a 31-year-old African American woman with a body mass index of 36.1 kg/m2, hypertension controlled with lisinopril, and diabetes with poor adherence to metformin and glipizide (hemoglobin A1c level, 13.9%). She was admitted for fever, dry cough, and abdominal discomfort of 5 days' duration. She was positive for SARS-CoV-2 by reverse transcriptase polymerase chain reaction testing of a nasopharyngeal swab specimen and was treated with a course of azithromycin and 2 days of hydroxychloroquine. At discharge, she was afebrile and her oxygen saturation was 95% on room air.The patient returned 12 days later with sudden fever; throbbing, left-sided neck pain; nausea; and vomiting. She had a fever of 39.8 °C, with sinus tachycardia of approximately 120 beats/min on electrocardiography. Her physical examination was remarkable for parotitis. A computed tomography scan of her neck showed bilaterally enlarged parotid glands and swelling in the posterior nasopharynx to oropharynx, and a computed tomography scan of her chest showed interval improvement of bibasilar ground-glass opacities, with cervical and anterior mediastinal lymphadenopathy. Reverse transcriptase polymerase chain reaction of a new nasopharyngeal swab was negative for SARS-CoV-2. Laboratory results at the time showed an elevated leukocyte count of 17.7 × 109 cells/L, a D-dimer level of 2.48 nmol/L, and C-reactive protein levels trending upward (Table). While she was being evaluated for hospital admission, she developed hemodynamic instability and ventricular fibrillation and could not be resuscitated. Permission for autopsy was granted by the next of kin, and this study was determined to be exempt by the institutional review board at Louisiana State University Health Sciences Center.Table. Laboratory StudiesGross abnormalities noted at autopsy (4 hours after death) were conjunctival injection, enlarged cervical and mediastinal lymph nodes, and vascular thrombi with focal surrounding hemorrhage in the left lower lung, which probably contributed to illness but were likely not the primary cause of death. Pulmonary microscopic examination showed focal acute hemorrhage and numerous megakaryocytes, consistent with our previously reported findings (2). Most of the lung showed predominantly reparative changes. Flow cytometry of an enlarged cervical lymph node revealed reactive changes, with a ratio of CD4 to CD8 T cells of 3:1.The heart had a grossly normal appearance, without evidence of coronary artery aneurysm, atherosclerosis, or stenosis. Microscopically, however, endotheliitis and vasculitis were present, diffusely involving the small cardiac vessels and extending into the surrounding epicardial fat and interstitial spaces (Figure, A and B). There was no lymphocytic infiltrate of the myocardium (2, 3). The vasculitis was composed of numerous neutrophils (Figure, C), as well as CD4+>CD8+ lymphocytes (Figure, E and F). Inflammation was not present in the coronary arteries or larger blood vessels (Figure, D). Similar inflammation was noted in occasional portal triad vessels within the liver (Figure, G).Figure. Pathologic characteristics of cardiac endotheliitis and multisystem vasculitis.A. Intact cardiac myocytes with a pattern of endotheliitis and vasculitis involving intervening small blood vessels and interstitial spaces, seen throughout extensive sampling of the heart (hematoxylin–eosin stain). B. Myeloperoxidase immunostain highlighting a prominent neutrophilic component to the inflammation in small vessels (compare with panel D). C. Low-power image of a cardiac blood vessel with inflammatory cuffing (blue arrow) and no evidence of direct myocardial involvement. D. Myeloperoxidase stain showing no significant endothelial inflammation in a coronary artery. E. CD4 immunostain showing CD4+ lymphocytes around small blood vessels in the epicardial fat, with large vessels relatively spared. F. CD8 immunostain showing reduced numbers of CD8+ compared with CD4+ lymphocytes. G. A similar neutrophilic vasculitis was seen in occasional portal triads of the liver, involving small arteries and veins with surrounding congestion and no direct inflammation of hepatocytes. Levels of aspartate aminotransferase and alanine aminotransferase became elevated just before death (Table). Download figure Download PowerPoint Discussion: Multisystem inflammatory syndrome is currently defined as fever, systemic inflammation, end-organ dysfunction, or symptoms similar to Kawasaki disease or toxic shock syndrome (4, 5). The clinical picture in this adult patient of sudden lymphadenopathy and parotitis combined with small-vessel cardiac vasculitis after COVID-19 is strongly suggestive of a similar systemic inflammatory process. Of note, the coronary arteries were spared, and neutrophils were identified along with CD4+>CD8+ lymphocytes. The appearance was not that of a lymphocytic or eosinophilic myocarditis, and cardiac myocytes did not seem to be the target of the inflammatory process.The autopsy was also significant for the presence of new pulmonary thrombi in a background of otherwise reparative changes in the lungs. These thrombi indicate a potential for hypercoagulability affecting the pulmonary vasculature beyond the initial course of COVID-19, as well as the need for continued monitoring of laboratory markers and possible anticoagulation.Our report highlights the potential for serious complications due to endothelial damage and describes potential pathologic characteristics of MIS after COVID-19, a possible mimicker of true myocarditis. Careful monitoring of laboratory markers of inflammation, as well as therapeutic intervention to target this inflammatory process, may improve patient outcomes.References1. Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19 [Letter]. Lancet. 2020;395:1417-1418. [PMID: 32325026] doi:10.1016/S0140-6736(20)30937-5 CrossrefMedlineGoogle Scholar2. Fox SE, Akmatbekov A, Harbert JL, et al. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. Lancet Respir Med. 2020;8:681-686. [PMID: 32473124] doi:10.1016/S2213-2600(20)30243-5 CrossrefMedlineGoogle Scholar3. Fox SE, Li G, Akmatbekov A, et al. Unexpected features of cardiac pathology in COVID-19 infection [Letter]. Circulation. 2020. [PMID: 32689809] doi:10.1161/CIRCULATIONAHA.120.049465 CrossrefMedlineGoogle Scholar4. Cheung EW, Zachariah P, Gorelik M, et al. Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City. JAMA. 2020. [PMID: 32511676] doi:10.1001/jama.2020.10374 CrossrefMedlineGoogle Scholar5. Viner RM, Whittaker E. Kawasaki-like disease: emerging complication during the COVID-19 pandemic. Lancet. 2020;395:1741-1743. [PMID: 32410759] doi:10.1016/S0140-6736(20)31129-6 CrossrefMedlineGoogle Scholar Comments 0 Comments Sign In to Submit A Comment Nazmul HaqueNA3 August 2020 - Its effect (MIS in children) still persist after recovery from covid? Author, Article, and Disclosure InformationAuthors: Sharon E. Fox, MD, PhD; Fernanda S. Lameira, MD; Elizabeth B. Rinker, MD; Richard S. Vander Heide, MD, PhDAffiliations: Louisiana State University Health Sciences Center and Southeast Louisiana Veterans Health Care System, New Orleans, Louisiana (S.E.F.)Louisiana State University Health Sciences Center, New Orleans, Louisiana (F.S.L., E.B.R., R.S.V.)Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L20-0882.Corresponding Author: Sharon E. Fox, MD, PhD (e-mail, sfox3@lsuhsc.edu), and Richard S. Vander Heide, MD, PhD (e-mail, rvand3@lsuhsc.edu), 1901 Perdido Street, Department of Pathology MEB 5th Floor, New Orleans, LA 70112.Correction: This article was corrected on 21 August 2020 to correct the labels in the figure caption.This article was published at Annals.org on 29 July 2020. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byDecoding acute myocarditis in patients with COVID-19: Early detection through machine learning and hematological indicesCOVID-19 therapy directed against pathogenic mechanisms of severe acute respiratory syndrome coronavirus 2Multisystem inflammatory syndrome in systemic lupus erythematosus patient with COVID ‐19: Case report and reviewAssessment of myocardial function and cardiac performance using left ventricular global longitudinal strain in athletes after COVID-19: a follow-up studyKidney Issues Associated with COVID-19 DiseaseSuccessful Use of Granulocyte and Monocyte Adsorptive Apheresis in a Patient with Post-COVID-19 Multisystem Inflammatory Syndrome in AdultsAnalysis of Plasmablasts From Children With Kawasaki Disease Reveals Evidence of a Convergent Antibody Response to a Specific Protein EpitopeA global systematic review and meta-analysis on the emerging evidence on risk factors, clinical characteristics, and prognosis of multisystem inflammatory syndrome in Adults (MIS-A)COVID‐19: A trigger of autoimmune diseases2023 Chinese expert consensus on the impact of COVID-19 on the management of cardiovascular diseasesFatal multisystem inflammatory syndrome in a 78-year-old adult after severe COVID-19 pneumonia during 2022 Omicron variant epidemic in Shanghai, ChinaSpike Protein Impairs Mitochondrial Function in Human Cardiomyocytes: Mechanisms Underlying Cardiac Injury in COVID-19Application Potential of Luteolin in the Treatment of Viral PneumoniaCase report: Immune profiling links neutrophil and plasmablast dysregulation to microvascular damage in post-COVID-19 Multisystem Inflammatory Syndrome in Adults (MIS-A)Immune and non-immune mechanisms that determine vasculitis and coronary artery aneurysm topography in Kawasaki disease and MIS-CMultisystem inflammatory syndrome in adults: Characteristics, treatment, and outcomesCOVID-19: A Comprehensive Review on Cardiovascular Alterations, Immunity, and Therapeutics in Older AdultsMultisystem inflammatory syndrome in adults: a case report and review of the literatureCardiac Changes Related to COVID-19 in Athletes: A Brief ReviewIndependent Predictors of Mortality in COVID-19 Myocardial Injury: The Role of Troponin Levels, GRACE Score, SOFA Score, and TIMI ScoreCardiovascular manifestations identified by multi-modality imaging in patients with long COVIDDiscrepancy between biomarkers of lung injury and 1‐year mortality in COVID ‐19Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?Post COVID-19 complications, adjunct therapy explored, and steroidal after effectsThe emerging threat of multisystem inflammatory syndrome in adults (MIS-A) in COVID-19: A systematic reviewCoronary microvascular dysfunction is common in patients hospitalized with COVID ‐19 infectionMultisystem inflammatory syndrome in adults: A systematic review and meta-analysis of the rheumatological spectrum of complications post COVID-19 infectionSARS-CoV-2 Spike Protein in Intestinal Cells of a Patient with Coronavirus Disease 2019 Multisystem Inflammatory SyndromeChest pain and coronary endothelial dysfunction after recovery from COVID‐19: A case seriesHypertension and COVID-19: Current Evidence and PerspectivesEndothelial contribution to COVID-19: an update on mechanisms and therapeutic implicationsTargeting Arginine in COVID-19-Induced Immunopathology and VasculopathyVascular endotheliitis associated with infections: Its pathogenetic role and therapeutic implicationIncidence of cardiac complications following COVID-19 infection: An umbrella meta-analysis studyPrevalence and Clinical Implications of COVID-19 MyocarditisST-Elevation Myocardial Infarction as a Late Complication of Mild Coronavirus Disease 2019 Infection: A Case ReportMyocardial infarction with non-obstructive coronary artery in a middle-aged woman with COVID-19.Caught Red‐HandedClinico-histopathologic and single-nuclei RNA-sequencing insights into cardiac injury and microthrombi in critical COVID-19Myocardial Injury in CoViD19Correlation of AKI with risk factors, ventilatory support, renal replacement therapy in a cohort of COVID-19 patientsInvestigation of endothelial dysfunction and arterial stiffness in multisystem inflammatory syndrome in childrenFundamentals in Covid-19-Associated Thrombosis: Molecular and Cellular AspectsThe intersection of COVID-19 and autoimmunityCurrent Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome in ChildrenChemokine-Based Therapeutics for the Treatment of Inflammatory and Fibrotic Convergent Pathways in COVID-19Sudden Cardiac Death Caused by Cardiac Small Vessel Vasculitis after COVID-19 Vaccination (BNT162b2 nCov-19): A Case ReportMultisystem inflammatory syndrome in an adult with involvement of the skin, lymph nodes, muscle, heart, liver and kidneysCOVID-19: the Risk to AthletesMultisystem Inflammatory Syndrome in an Adult With COVID-19—A Trial of AnakinraSARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid AntagonismPathophysiology of COVID-19-associated acute kidney injuryEndothelial Dysfunction as a Component of Severe Acute Respiratory Syndrome Coronavirus 2–Related Multisystem Inflammatory Syndrome in Children With ShockAcute Myocardial Injury and Rhabdomyolysis in COVID-19 Patients: Incidence and MortalityA Comparison of the Clinical, Viral, Pathologic, and Immunologic Features of Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus 2019 (COVID-19) DiseasesMultisystem inflammatory syndrome in adults: A case in a previously healthy adultClinical Characteristics of Multisystem Inflammatory Syndrome in AdultsManagement of Multisystem Inflammatory Syndrome in Children Associated with COVID-19 InfectionPathophysiologie von COVID-19 und deren mögliche Bedeutung für Long-COVIDCOVID-19 myocarditis: quantitative analysis of the inflammatory infiltrate and a proposed mechanismReply to Padhi et alA novel coronavirus meets the cardiovascular system: Society for Cardiovascular Pathology Symposium 2021Enhanced Expression of Autoantigens During SARS-CoV-2 Viral InfectionCase Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic MicroangiopathyElectrical Storm With Incessant Ventricular Tachycardia in a COVID-19 Patient: Review of Current EvidenceThe Notch Pathway: A Link Between COVID-19 Pathophysiology and Its Cardiovascular ComplicationsMultiple system inflammatory syndrome associated with SARS-CoV-2 infection in an adult and an adolescentCOVID-19: The Heart of the Matter—Pathological Changes and a Proposed MechanismCell-Type Apoptosis in Lung during SARS-CoV-2 InfectionCOVID-19 and Cardiovascular DiseaseHypertension, a Moving Target in COVID-19Clinical, Angiographic Profile and Immediate Outcome of COVID-19 Patients Presenting as Acute Coronary Syndrome: An Observational StudyCOVID-19 vasculitis and novel vasculitis mimicsMultisystem Inflammatory Syndrome in AdultsSARS-CoV-2 leads to a small vessel endotheliitis in the heartGamut of Cardiac Manifestations and Complications of COVID-19: A Contemporary ReviewCoronavirus Desease 2019 (COVID-19) in Children: Lessons from Pediatric RheumatologyCOVID-19 Presenting as Major Thromboembolic Events: Virchow’s Triad Revisited and Clinical Considerations of Therapeutic Anticoagulation 15 December 2020Volume 173, Issue 12 Page: 1025-1027 Keywords Autopsy Blood vessels Coronary arteries COVID-19 Fevers Heart Inflammation Lungs Lymphocytes Vasculitis ePublished: 29 July 2020 Issue Published: 15 December 2020 Copyright & PermissionsCopyright © 2020 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...